FMR LLC 13D and 13G filings for Theseus Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-08-10 08:19 am Sale | 2023-08-09 | 13G | THESEUS PHARMACEUTICALS INC CO THRX | FMR LLC | 1,194 0.002% | -2,497,161 (-99.95%) | Filing |
| 2023-02-09 12:39 pm Sale | 2023-02-09 | 13G | THESEUS PHARMACEUTICALS INC CO THRX | FMR LLC | 2,498,355 6.453% | -694,308 (-21.75%) | Filing |
| 2022-12-12 08:41 am Sale | 2022-12-09 | 13G | THESEUS PHARMACEUTICALS INC CO THRX | FMR LLC | 3,192,663 8.246% | -2,256,006 (-41.40%) | Filing |
| 2022-02-09 10:01 am Purchase | 2022-02-08 | 13G | THESEUS PHARMACEUTICALS INC CO THRX | FMR LLC | 5,448,669 14.078% | 1,494,953 (+37.81%) | Filing |
| 2021-11-10 12:24 pm Purchase | 2021-11-09 | 13G | THESEUS PHARMACEUTICALS INC CO THRX | FMR LLC | 3,953,716 10.534% | 3,953,716 (New Position) | Filing |